Search Results - "Erez, Baruch"

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients by Baruch, Erez N, Youngster, Ilan, Ben-Betzalel, Guy, Ortenberg, Rona, Lahat, Adi, Katz, Lior, Adler, Katerina, Dick-Necula, Daniela, Raskin, Stephen, Bloch, Naamah, Rotin, Daniil, Anafi, Liat, Avivi, Camila, Melnichenko, Jenny, Steinberg-Silman, Yael, Mamtani, Ronac, Harati, Hagit, Asher, Nethanel, Shapira-Frommer, Ronnie, Brosh-Nissimov, Tal, Eshet, Yael, Ben-Simon, Shira, Ziv, Oren, Khan, Md Abdul Wadud, Amit, Moran, Ajami, Nadim J, Barshack, Iris, Schachter, Jacob, Wargo, Jennifer A, Koren, Omry, Markel, Gal, Boursi, Ben

“…The gut microbiome has been shown to influence the response of tumors to anti-PD-1 (programmed cell death-1) immunotherapy in preclinical mouse models and…”
Get full text

Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls by Darnell, Eli P., Mooradian, Meghan J., Baruch, Erez N., Yilmaz, Melis, Reynolds, Kerry L.

“…Purpose of Review While immune checkpoint inhibitor (ICI) therapy has improved melanoma patient outcomes, it has also resulted in the rise of unique…”
Get full text

Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence by Harel, Michal, Ortenberg, Rona, Varanasi, Siva Karthik, Mangalhara, Kailash Chandra, Mardamshina, Mariya, Markovits, Ettai, Baruch, Erez N., Tripple, Victoria, Arama-Chayoth, May, Greenberg, Eyal, Shenoy, Anjana, Ayasun, Ruveyda, Knafo, Naama, Xu, Shihao, Anafi, Liat, Yanovich-Arad, Gali, Barnabas, Georgina D., Ashkenazi, Shira, Besser, Michal J., Schachter, Jacob, Bosenberg, Marcus, Shadel, Gerald S., Barshack, Iris, Kaech, Susan M., Markel, Gal, Geiger, Tamar

“…Immunotherapy has revolutionized cancer treatment, yet most patients do not respond. Here, we investigated mechanisms of response by profiling the proteome of…”
Get full text

Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600–mutant metastatic melanoma by Ben-Betzalel, Guy, Baruch, Erez N., Boursi, Ben, Steinberg-Silman, Yael, Asher, Nethanel, Shapira-Frommer, Ronnie, Schachter, Jacob, Markel, Gal

“…BRAF inhibitors (BRAFi) and MEK inhibitors (MEKi) are among the cornerstones of metastatic melanoma therapy demonstrating excellent response rates with…”
Get full text

Point of injury tourniquet application during Operation Protective Edge-What do we learn? by Shlaifer, Amir, Yitzhak, Avraham, Baruch, Erez N, Shina, Avi, Satanovsky, Alexandra, Shovali, Amiram, Almog, Ofer, Glassberg, Elon

“…Hemorrhage is a leading cause of preventable death on the battlefield. Timely tourniquet application to massively bleeding extremity wounds is critical for…”
Get full text

Fecal microbiota transplantation as a mean of overcoming immunotherapy-resistant cancers – hype or hope? by Baruch, Erez N., Gaglani, Tanmay, Wargo, Jennifer A.

Get full text

TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma by Roszik, Jason, Markovits, Ettai, Dobosz, Paula, Layani, Adi, Slabodnik-Kaner, Keren, Baruch, Erez N., Ben-Betzalel, Guy, Grimm, Elizabeth, Berger, Raanan, Sidi, Yehezkel, Schachter, Jacob, Shapira-Frommer, Ronnie, Avni, Dror, Markel, Gal, Leibowitz-Amit, Raya

“…Immunotherapy with checkpoint inhibitors revolutionized melanoma treatment in both the adjuvant and metastatic setting, yet not all metastatic patients…”
Get full text

CXCR2 Expression in Tumor Cells is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma by SAINTIGNY, Pierre, MASSARELLI, Erminia, LIZHANG, YUAN PING, BEHRENS, Carmen, SOLIS SOTO, Luisa M, HEYMACH, John V, KIM, Edward S, HERBST, Roy S, LIPPMAN, Scott M, WISTUBA, Ignacio I, KI HONG, Waun, LIN, Steven, KURIE, Jonathan M, JA SEOK KOO, AHN, Young-Ho, YULONG CHEN, GOSWAMI, Sangeeta, EREZ, Baruch, O'REILLY, Michael S, DIANELIU, JACK LEE, J

“…CXCR2 in non-small cell lung cancer (NSCLC) has been studied mainly in stromal cells and is known to increase tumor inflammation and angiogenesis. Here, we…”
Get full text

Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma by Amit, Moran, Liu, Chuan, Mansour, Jobran, Gleber‐Netto, Frederico O., Tam, Samantha, Baruch, Erez N., Aashiq, Mohamed, El‐Naggar, Adel K., Moreno, Amy C., Rosenthal, David I., Glisson, Bonnie S., Ferrarotto, Renata, Wong, Michael K., Tsai, Kenneth, Flores, Elsa R., Migden, Michael R., Silverman, Deborah A., Li, Goujun, Khanna, Anshu, Goepfert, Ryan P., Nagarajan, Priyadharsini, Weber, Randal S., Myers, Jeffrey N., Gross, Neil D.

“…Background The survival benefit of elective neck dissection (END) for patients with cutaneous squamous cell carcinoma (cSCC) of the head and neck and no…”
Get full text

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response by Spencer, Christine N, McQuade, Jennifer L, Gopalakrishnan, Vancheswaran, McCulloch, John A, Vetizou, Marie, Cogdill, Alexandria P, Khan, Md A Wadud, Zhang, Xiaotao, White, Michael G, Peterson, Christine B, Wong, Matthew C, Morad, Golnaz, Rodgers, Theresa, Badger, Jonathan H, Helmink, Beth A, Andrews, Miles C, Rodrigues, Richard R, Morgun, Andrey, Kim, Young S, Roszik, Jason, Hoffman, Kristi L, Zheng, Jiali, Zhou, Yifan, Medik, Yusra B, Kahn, Laura M, Johnson, Sarah, Hudgens, Courtney W, Wani, Khalida, Gaudreau, Pierre-Olivier, Harris, Angela L, Jamal, Mohamed A, Baruch, Erez N, Perez-Guijarro, Eva, Day, Chi-Ping, Merlino, Glenn, Pazdrak, Barbara, Lochmann, Brooke S, Szczepaniak-Sloane, Robert A, Arora, Reetakshi, Anderson, Jaime, Zobniw, Chrystia M, Posada, Eliza, Sirmans, Elizabeth, Simon, Julie, Haydu, Lauren E, Burton, Elizabeth M, Wang, Linghua, Dang, Minghao, Clise-Dwyer, Karen, Schneider, Sarah, Chapman, Thomas, Anang, Nana-Ama A S, Duncan, Sheila, Toker, Joseph, Malke, Jared C, Glitza, Isabella C, Amaria, Rodabe N, Tawbi, Hussein A, Diab, Adi, Wong, Michael K, Patel, Sapna P, Woodman, Scott E, Davies, Michael A, Ross, Merrick I, Gershenwald, Jeffrey E, Lee, Jeffrey E, Hwu, Patrick, Jensen, Vanessa, Samuels, Yardena, Straussman, Ravid, Ajami, Nadim J, Nelson, Kelly C, Nezi, Luigi, Petrosino, Joseph F, Futreal, P Andrew, Lazar, Alexander J, Hu, Jianhua, Jenq, Robert R, Tetzlaff, Michael T, Yan, Yan, Garrett, Wendy S, Huttenhower, Curtis, Sharma, Padmanee, Watowich, Stephanie S, Allison, James P, Cohen, Lorenzo, Trinchieri, Giorgio, Daniel, Carrie R, Wargo, Jennifer A

“…Gut bacteria modulate the response to immune checkpoint blockade (ICB) treatment in cancer, but the effect of diet and supplements on this interaction is not…”
Get full text

Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck by Amit, Moran, Liu, Chuan, Gleber‐Netto, Frederico O., Kini, Sameer, Tam, Samantha, Benov, Avi, Aashiq, Mohamed, El‐Naggar, Adel K., Moreno, Amy C., Rosenthal, David I., Glisson, Bonnie S., Ferrarotto, Renata, Wong, Michael K., Migden, Michael R., Baruch, Erez N., Li, Guojun, Khanna, Anshu, Goepfert, Ryan P., Nagarajan, Priyadharsini, Weber, Randal S., Myers, Jeffrey N., Gross, Neil D.

“…Background The prognostic performance of the recently updated American Joint Committee on Cancer lymph node classification of cutaneous head and neck squamous…”
Get full text

MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2 by Markovits, Ettai, Harush, Ortal, Baruch, Erez N, Shulman, Eldad D, Debby, Assaf, Itzhaki, Orit, Anafi, Liat, Danilevsky, Artem, Shomron, Noam, Ben-Betzalel, Guy, Asher, Nethanel, Shapira-Frommer, Ronnie, Schachter, Jacob, Barshack, Iris, Geiger, Tamar, Elkon, Ran, Besser, Michal J, Markel, Gal

“…Immunotherapy has revolutionized the treatment of advanced melanoma. Because the pathways mediating resistance to immunotherapy are largely unknown, we…”
Get more information

Does practice make perfect? Prospectively comparing effects of 2 amounts of practice on tourniquet use performance by Baruch, Erez N, Benov, Avi, Shina, Avi, Berg, Amy L, Shlaifer, Amir, Glassberg, Elon, Aden, 3rd, James K, Bader, Tarif, Kragh, Jr, John F, Yitzhak, Avraham

“…Although a lifesaving skill, currently, there is no consensus for the required amount of practice in tourniquet use. We compared the effect of 2 amounts of…”
Get full text

Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma by Galore-Haskel, Gilli, Baruch, Erez N, Berg, Amy L, Barshack, Iris, Zilinsky, Itzhak, Avivi, Camila, Besser, Michal J, Schachter, Jacob, Markel, Gal

“…Intercellular adhesion molecule 1 (ICAM-1) protein is an important adhesion molecule that facilitates metastasis on one hand, and on the other hand supports…”
Get full text

Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis by TAKAHASHI, Osamu, KOMAKI, Ritsuko, EREZ, Baruch, HOSHO, Keiko, HERBST, Roy S, O'REILLY, Michael S, SMITH, Paul D, JÜRGENSMEIE, Juliane M, RYAN, Anderson, NEBIYOU BEKELE, B, WISTUBA, Ignacio I, JACOBY, Jorg J, KORSHUNOVA, Maria V, BIERNACKA, Anna

“…Ras/Raf/mitogen-activated protein-extracellular signal-regulated kinase (ERK) kinase (MEK)/ERK signaling is critical for tumor cell proliferation and survival…”
Get full text

Abstract PO-074: The evolution of the tumor immune microenvironment in immunosuppressed patients with cutaneous squamous cell carcinoma by Glaun, Mica D. E., Gleber-Netto, Frederico O., Nagarajan, Priyadharsini, Xie, Tongxin, Akhter, Shamima, Chen, Yu Han, Baruch, Erez Baruch N., Wong, Michael K., Chu, Emily Y., Tsai, Kenneth Y., Flores, Elsa R., Silverman, Deborah A., Goepfert, Ryan P., Cobanoglu, Murat, Burks, Jared, Sharma, Padmanee, Allison, James P., Myers, Jeffrey N., Gross, Neil D., Amit, Moran

“…Abstract Immunosuppression is a major risk and prognostic factor for cutaneous squamous cell carcinoma (cSCC). Immune checkpoint inhibition is approved for the…”
Get full text

Confidence-Competence Mismatch and Reasons for Failure of Non-Medical Tourniquet Users by Baruch, Erez N., Kragh, John F., Berg, Amy L., Aden, James K., Benov, Avi, Shina, Avi, Shlaifer, Amir, Ahimor, Alon, Glassberg, Elon, Yitzhak, Avraham

“…Objective: Tourniquet application is a lifesaving skill taught worldwide in first aid bleeding control courses. We observed performance among non-medical users…”
Get full text

Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls by Darnell, Eli P., Mooradian, Meghan J., Baruch, Erez N., Yilmaz, Melis, Reynolds, Kerry L.

Get full text

Extending a Helping Hand: A Comparison of Israel Defense Forces Medical Corps Humanitarian Aid Field Hospitals by Glick, Yuval, Baruch, Erez N, Tsur, Avishai M, Berg, Amy L, Yifrah, Dror, Yitzhak, Avraham, Dagan, David, Bader, Tarif

“…During the past 6 years the Israel Defense Forces Medical Corps (IDF-MC) deployed three humanitarian delegation field hospitals (HDFHs) in disaster zones…”
Get full text

ADAR1-mediated regulation of melanoma invasion by Nemlich, Yael, Baruch, Erez Nissim, Besser, Michal Judith, Shoshan, Einav, Bar-Eli, Menashe, Anafi, Liat, Barshack, Iris, Schachter, Jacob, Ortenberg, Rona, Markel, Gal

“…Melanoma cells use different migratory strategies to exit the primary tumor mass and invade surrounding and subsequently distant tissues. We reported…”
Get full text